N-甲基-4-吡啶甲胺 | 6971-44-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-甲基-4-吡啶甲胺
• 中文别名: N-甲基-N-(4-吡啶甲基)胺
• 英文名称: N-methylpyridine-4-methylamine
• 英文别名: N-methyl-1-(pyridin-4-yl)methanamine；N-methyl-1-pyridin-4-ylmethanamine
• CAS: 6971-44-4
• 化学式: C₇H₁₀N₂
• mdl: MFCD00066937
• 分子量: 122.17
• InChiKey: DNBWGFKLIBQQSL-UHFFFAOYSA-N

物化性质

• 沸点：
  86 °C
• 密度：
  0.982
• 闪点：
  75℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.285
• 拓扑面积：
  24.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933399090
• 储存条件：
  室温且干燥

SDS

Name:	N-Methyl-N-(4-pyridinylmethyl)amine Material Safety Data Sheet
Synonym:	None Known
CAS:	6971-44-4

Section 1 - Chemical Product MSDS Name:N-Methyl-N-(4-pyridinylmethyl)amine Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
6971-44-4	N-Methyl-N-(4-pyridinylmethyl)amine	97+	230-198-6

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Chronic exposure may cause effects similar to those of acute exposure.

---

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give anything by mouth to an unconscious person.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Discard contaminated shoes. Use only with adequate ventilation.
Storage:
Keep container closed when not in use. Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 6971-44-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 86 deg C @ 3mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H10N2
Molecular Weight: 122.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
None reported.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acid chlorides.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 6971-44-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-Methyl-N-(4-pyridinylmethyl)amine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Pseudomonas putida:

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, LIQUID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 2735
Packing Group: III
IMO
Shipping Name: AMINES, LIQUID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 2735
Packing Group: III
RID/ADR
Shipping Name: AMINES, LIQUID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 2735
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 6 Keep under nitrogen.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 6971-44-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6971-44-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6971-44-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-甲基-4-吡啶甲胺 在 palladium on activated charcoal 氢气 、 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 11.0h， 生成 4'-demethyl-4β-<2-ethyl>-4-desoxypodophyllotoxin
  参考文献：
  名称：

  抗肿瘤药。3.包含4'-O-脱甲基-4-脱氧鬼臼毒素的羟基，氨基和酰胺基的4个β-烷基衍生物的合成和生物活性作为抗肿瘤剂。

  摘要：

  合成了一系列4'-O-脱甲基-4-脱氧鬼臼毒素的4个β-烷基（7-10），4个β-氨基烷基（12a-y）和4个β-酰胺基烷基衍生物（14a-g），并且评估了它们的细胞毒性，对DNA拓扑异构酶II（Topo II）的抑制作用以及微管蛋白聚合作用。12a-y和14a-g的所有衍生物均不抑制微管蛋白聚合。许多化合物表现出细胞毒性和对Topo II的抑制作用。特别是12o，12s，12t和12u会强烈抑制Topo II（分别为IC50（microM）32.5、60.9、58.8和33.6），并且对P388细胞具有很强的细胞毒性（IC50（M）1.0、4.1、3.3和分别为3.0 x 10（-9）和VP-16（IC50（microM）59.2，IC50（M）1 x 10（-8））。这些化合物的体内抗肿瘤活性几乎等于或优于VP-16（L1210，P388，

  DOI：

  10.1021/jm00064a002
• 作为产物：
  描述：

  N-(4-picolyl)formamide 在 氢氧化钾 、 potassium hydride 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 生成 N-甲基-4-吡啶甲胺
  参考文献：
  名称：

  Formamidines as α-amino carbanion precursors. The synthesis of 2-arylpiperidines, -pyrrolidines, and nicotine analogs

  摘要：

  DOI：

  10.1016/s0040-4039(00)98247-9

文献信息

• SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY
  申请人：OOST Thorsten

  公开号：US20140057916A1

  公开（公告）日：2014-02-27

  This invention relates to substituted 4-pyridones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection, and oncological diseases.

  这项发明涉及式1的取代4-吡啶酮及其作为中性粒细胞弹性蛋白酶活性抑制剂的用途，包含这些化合物的药物组合物，以及将其用作治疗和/或预防肺部、胃肠道和泌尿系统疾病、皮肤和眼睛的炎症性疾病以及其他自身免疫和过敏性疾病、移植物排斥反应和肿瘤性疾病的药剂的方法。
• Development of a Simple and Efficient Solution-Phase Parallel Synthesis of Flexible Non-Steroidal Estradiol Mimics
  作者：Guy Djigoue、Rene Maltais、Donald Poirier

  DOI：10.2174/1386207317666140915125620

  日期：2014.11.7

  An efficient parallel synthesis was designed to provide libraries of estradiol mimics that can potentially interact with different biological targets associated with estradiol-related diseases. Two libraries of 75 members each were synthesized around a non-steroidal core by adding three levels of molecular diversity. Hydroxybenzaldehydes (1st level of diversity), protected as a methoxymethyl ether

  设计了一种有效的平行合成方法，以提供可能与与雌二醇相关疾病相关的不同生物靶标相互作用的雌二醇模拟物文库。通过添加三个水平的分子多样性，围绕非甾体核心合成了两个75个成员的文库。被保护为甲氧基甲基醚的羟基苯甲醛（第1级多样性）在还原胺化条件下首先与伯胺（第2级多样性）反应。接下来，所得仲胺与4-溴-1,2-环氧丁烷反应，以提供作为第三级多样性的前体的环氧化物衍生物。然后使用各种亲核试剂打开每个环氧化物。
• 4-PHENYLPIPERAZIN-1-YL)ACYLPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS
  申请人：Dos Santos Victor

  公开号：US20070021609A1

  公开（公告）日：2007-01-25

  The invention relates to substituted (4-phenylpiperazin-1-yl)acylpiperidine derivatives of formula (I) in the form of a base or an addition salt with an acid, and also in the form of a hydrate or solvate, and their preparation process and therapeutic application.

  这项发明涉及以碱或酸的加成盐形式存在的取代(4-苯基哌嗪-1-基)酰基哌啶衍生物（I）以及以水合物或溶剂合物形式存在的这些衍生物，以及它们的制备过程和治疗应用。
• Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents
  作者：Rui Xie、Yan Li、Pingwah Tang、Qipeng Yuan

  DOI：10.1016/j.ejmech.2017.08.041

  日期：2018.1

  HDAC2 selective inhibitors. We also rationalize the high potency and selectivity of compound M122 by molecular docking. Further investigation showed that M101, M122 and M133 could inhibit colony formation of human hepatocellular carcinoma cell line SMMC7721. Furthermore, M101, M122 and M133 remarkably induced apoptosis in SMMC7721 cancer cells. M101 and M133 were found to potently induce SMMC7721 cancer

  设计并合成了一系列以二硫代氨基甲酸酯为帽基的新型2-氨基苯甲酰胺，作为组蛋白脱乙酰基酶（HDAC）抑制剂。大多数新合成的化合物对多种人类肿瘤细胞系均显示出强大的抗增殖活性。最有效的化合物M101，M122和M133在IC 50的作用下，对6种癌细胞系表现出显着增强的抗癌能力与CS055（2.28〜> 26μM）和MS275（0.47–6.74μM）相比，该值低至0.54–2.49μM。HDAC同工型选择性测定表明M101，M122和M133是HDAC1和HDAC2选择性抑制剂。我们还通过分子对接合理化了化合物M122的高效价和选择性。进一步的研究表明，M101，M122和M133可以抑制人肝癌细胞SMMC7721的集落形成。此外，M101，M122和M133显着诱导SMMC7721癌细胞的凋亡。发现M101和M133在G2 / M期有效诱导SMMC7721癌细胞周期停滞。这项研究表明，引入
• CHEMICAL COMPOUNDS
  申请人：Deng Jianghe

  公开号：US20090143372A1

  公开（公告）日：2009-06-04

  The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I: where R1, R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  这项发明涉及新型吲哚羧酰胺衍生物。具体而言，该发明涉及符合以下式I的化合物： 其中R1、R2、R3、U和V如下定义，并且其药学上可接受的盐。该发明的化合物是IKK2的抑制剂，可用于治疗与不当IKK2（也称为IKKβ）活性相关的疾病，如类风湿性关节炎、哮喘和慢性阻塞性肺病（COPD）。因此，该发明进一步涉及包含该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包含该发明化合物的药物组合物抑制IKK2活性和治疗相关疾病的方法。

表征谱图